These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28445934)

  • 1. Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
    Zhu XX; Yan YW; Ai CZ; Jiang S; Xu SS; Niu M; Wang XZ; Zhong GS; Lu XF; Xue Y; Tian S; Li G; Tang S; Jiang YZ
    Oncotarget; 2017 Apr; 8(15):24483-24490. PubMed ID: 28445934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
    Wang X; Lyu J; Ji A; Zhang Q; Liao G
    Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.
    Su CL; Deng TR; Shang Z; Xiao Y
    Int J Hematol; 2015 Jul; 102(1):76-85. PubMed ID: 25939703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
    Liu Y; Huang X; Guo L; Luo N
    Urol Int; 2022; 106(3):304-312. PubMed ID: 33789312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
    Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
    PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
    Park SJ; Shim JW; Park HS; Eum DY; Park MT; Mi Yi J; Choi SH; Kim SD; Son TG; Lu W; Kim ND; Yang K; Heo K
    Oncogene; 2016 Mar; 35(10):1292-301. PubMed ID: 26028027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells.
    Yang Z; He L; Lin K; Zhang Y; Deng A; Liang Y; Li C; Wen T
    Clin Cancer Res; 2017 Nov; 23(21):6673-6685. PubMed ID: 28765327
    [No Abstract]   [Full Text] [Related]  

  • 15. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.
    Celik H; Koh WK; Kramer AC; Ostrander EL; Mallaney C; Fisher DAC; Xiang J; Wilson WC; Martens A; Kothari A; Fishberger G; Tycksen E; Karpova D; Duncavage EJ; Lee Y; Oh ST; Challen GA
    Cancer Cell; 2018 Nov; 34(5):741-756.e8. PubMed ID: 30423295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome.
    da Rocha ST; Boeva V; Escamilla-Del-Arenal M; Ancelin K; Granier C; Matias NR; Sanulli S; Chow J; Schulz E; Picard C; Kaneko S; Helin K; Reinberg D; Stewart AF; Wutz A; Margueron R; Heard E
    Mol Cell; 2014 Jan; 53(2):301-16. PubMed ID: 24462204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
    He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T
    Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
    Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
    Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N
    Gu C; Wang Z; Zhou N; Li G; Kou Y; Luo Y; Wang Y; Yang J; Tian F
    Mol Cancer; 2019 Nov; 18(1):168. PubMed ID: 31760940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.